Cencora Inc. (COR) reported $332.77B of revenue for the twelve months ended Jun 30, 2026. That is up 5.1% from the year before. Revenue for fiscal 2025 was $321.33B.

Yes. Cencora Inc. earned $2.62B in net income for the twelve months ended Jun 30, 2026, a net margin of 0.8%.

How much cash and debt does COR have?

Cencora Inc. reported $2.82B in cash and cash equivalents and $11.72B of debt on its most recent balance sheet in SEC filings.

How fast is COR revenue growing?

Cencora Inc.'s revenue changed +9.3% in fiscal 2025, to $321.33B. Its compound annual growth rate was +11.1% over 5 years and +9.0% over 10 years.

What is COR gross margin?

Cencora Inc.'s gross profit was $13.22B on $332.77B of revenue for the twelve months ended Jun 30, 2026, a gross margin of 4.0%.

What is COR free cash flow?

Cencora Inc. generated $4.06B of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of $4.82B less capital expenditures.

What is COR earnings per share?

Diluted earnings per share were $13.47 for the twelve months ended Jun 30, 2026, from SEC filings, restated for any stock split those filings show.

When did COR last report financial results?

The latest statements here come from Cencora Inc.'s 10-Q filed on Aug 5, 2026, covering the period ended Jun 30, 2026.

Where does this COR financial data come from?

Quantisnow builds these statements from the structured XBRL data Cencora Inc. files with the SEC. It is provided for information only and is not investment advice.

Financials · COR

Cencora Inc. (COR) financials

For the twelve months ended Jun 30, 2026, Cencora Inc. reported $332.77B of revenue and $2.62B of net income.

Revenue, TTM: $332.77B
Revenue growth, YoY: +5.1%
Net income, TTM: $2.62B
Net income growth, YoY: +38.3%
Net margin: 0.8%
Free cash flow, TTM: $4.06B
EPS, diluted, TTM: $13.47
Cash: $2.82B
Total debt: $11.72B
P/E: 24.25
P/S: 0.19
Market cap: $63.65B

Annual revenue$321.33B

FY2016FY2025

Annual net income$1.55B

FY2016FY2025

Annual free cash flow$3.21B

FY2016FY2025

COR revenue and earnings growth

COR revenueQ3 2026$84.75B

Quarter YoY: +5.1%
QoQ: +8.2%
FY YoY: +9.3%
5Y CAGR: +11.1%
10Y CAGR: +9.0%

COR revenue was $84.75B in fiscal Q3 2026 (ended Jun 30, 2026), up 5.1% from a year earlier and up 8.2% from the prior quarter. For the full fiscal 2025 it was $321.33B, up 9.3% from fiscal 2024. Compound annual growth was +11.1% over 5 years and +9.0% over 10 years. It rose in each of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

COR net incomeQ3 2026$763.52M

Quarter YoY: +11.1%
QoQ: -53.5%
FY YoY: +3.0%

COR net income was $763.52M in fiscal Q3 2026 (ended Jun 30, 2026), up 11.1% from a year earlier and down 53.5% from the prior quarter. For the full fiscal 2025 it was $1.55B, up 3.0% from fiscal 2024. It rose in 3 of the last 4 fiscal years.

COR EPSQ3 2026$3.94

Quarter YoY: +11.9%
QoQ: -53.1%
FY YoY: +5.7%

COR diluted EPS was $3.94 in fiscal Q3 2026 (ended Jun 30, 2026), up 11.9% from a year earlier and down 53.1% from the prior quarter. For the full fiscal 2025 it was $7.96, up 5.7% from fiscal 2024.

COR free cash flowQ3 2026$2.43B

QoQ: +107.0%
FY YoY: +7.0%
5Y CAGR: +11.8%
10Y CAGR: -1.4%

COR free cash flow was $2.43B in fiscal Q3 2026 (ended Jun 30, 2026), compared with -$73.97M a year earlier and up 107.0% from the prior quarter. For the full fiscal 2025 it was $3.21B, up 7.0% from fiscal 2024. Compound annual growth was +11.8% over 5 years and -1.4% over 10 years. It rose in 5 of the last 10 fiscal years.

Export CSV

Income statement

Income statement
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Revenue	$321.33B	$293.96B	$262.17B	$238.59B	$213.99B	$189.89B	$179.59B	$167.94B	$153.14B	$146.85B
Cost of revenue	$309.85B	$284.05B	$253.21B	$230.29B	$207.05B	$184.70B	$174.45B	$163.33B	$148.60B	$142.58B
Gross profit	$11.48B	$9.91B	$8.96B	$8.30B	$6.94B	$5.19B	$5.14B	$4.61B	$4.55B	$4.27B
Selling, general and admin	$6.49B	$5.66B	$5.31B	$4.85B	$3.59B	$2.77B	$2.66B	$2.46B	$2.13B	$2.09B
Operating income	$2.63B	$2.18B	$2.34B	$2.37B	$2.35B	-$5.14B	$1.11B	$1.44B	$1.06B	$1.53B
Pre-tax income	$2.26B	$2.00B	$2.16B	$2.18B	$2.22B	-$5.29B	$967.11M	$1.18B	$917.89M	$1.39B
Income tax	$690.52M	$484.70M	$428.26M	$516.52M	$677.25M	-$1.89B	$112.97M	-$438.47M	$553.40M	-$37.02M
Net income	$1.55B	$1.51B	$1.75B	$1.70B	$1.54B	-$3.41B	$855.37M	$1.66B	$364.48M	$1.43B
EPS, basic	$8.02	$7.60	$8.62	$8.15	$7.48	-$16.65	$4.07	$7.61	$1.67	$6.73
EPS, diluted	$7.96	$7.53	$8.53	$8.04	$7.39	-$16.65	$4.04	$7.53	$1.64	$6.32
Diluted shares	195.2M	200.3M	204.6M	211.2M	208.5M	204.8M	211.8M	220.3M	221.6M	226.0M

Balance sheet

Balance sheet
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Cash and equivalents	$4.36B	$3.13B	$2.59B	$3.39B	$2.55B	$4.60B	$3.37B	$2.49B	$2.44B	$2.74B
Receivables	$25.23B	$23.87B	$20.91B	$18.45B	$18.17B	$13.85B	$12.39B	$11.31B	$10.30B	$9.18B
Inventory	$20.49B	$19.00B	$17.45B	$15.56B	$15.37B	$12.59B	$11.06B	$11.92B	$11.46B	$10.72B
Current assets	$52.24B	$47.72B	$42.80B	$39.59B	$38.80B	$33.06B	$28.13B	$25.89B	$24.30B	$22.85B
Goodwill	$13.68B	$9.32B	$9.57B	$8.50B	$9.03B	$6.71B	$6.71B	$6.66B	$6.04B	$5.99B
Total assets	$76.59B	$67.10B	$62.56B	$56.56B	$57.34B	$44.27B	$39.17B	$37.67B	$35.32B	$33.64B
Current liabilities	$57.82B	$54.28B	$48.83B	$43.48B	$41.36B	$33.85B	$29.58B	$27.87B	$26.82B	$25.28B
Short-term debt	$117.78M	$576.33M	$641.34M	$1.07B	$300.21M	$501.26M	$139.01M	$151.66M	$12.12M	$610.21M
Long-term debt	$7.54B	$3.81B	$4.15B	$4.63B	$6.38B	$3.62B	$4.03B	$4.16B	$3.43B	$3.58B
Total debt	$7.66B	$4.39B	$4.79B	$5.70B	$6.68B	$4.12B	$4.17B	$4.31B	$3.44B	$4.19B
Total liabilities	$74.84B	$66.31B	$61.89B	$56.49B	$56.75B	$45.11B	$36.18B	$34.62B	$33.25B	$31.51B
Shareholders' equity	$1.51B	$786.74M	$666.29M	$71.27M	$584.41M	-$839.64M	$2.99B	$3.05B	$2.06B	$2.13B

Cash flow

Cash flow
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Operating cash flow	$3.88B	$3.48B	$3.91B	$2.70B	$2.67B	$2.21B	$2.34B	$1.41B	$1.50B	$3.18B
Capital expenditures	$667.98M	$487.17M	$458.36M	$496.32M	$438.22M	$369.68M	$310.22M	$336.41M	$466.40M	$464.62M
Free cash flow	$3.21B	$3.00B	$3.45B	$2.21B	$2.23B	$1.84B	$2.03B	$1.07B	$1.04B	$2.71B
Investing cash flow	-$4.98B	-$618.10M	-$2.60B	-$368.44M	-$6.14B	-$379.87M	-$375.83M	-$1.11B	-$498.04M	-$3.17B
Financing cash flow	$2.25B	-$2.33B	-$2.22B	-$1.75B	$1.95B	-$603.62M	-$1.09B	-$242.87M	-$1.31B	$565.07M
Dividends paid	$437.08M	$416.17M	$398.75M	$391.69M	$366.65M	$343.58M	$338.97M	$333.04M	$320.27M	$288.48M
Share repurchases	$435.47M	$1.49B	$1.18B	$483.70M	$82.15M	$420.45M	$674.03M	$639.24M	$329.93M	$2.27B
Stock-based compensation	$147.96M	$148.00M	$124.62M	$93.40M	$99.59M	$74.41M	$58.87M	$62.32M	$62.21M	$64.99M
Depreciation and amortization	$1.05B	$1.09B	$963.90M	$693.89M	$505.17M	$391.06M	$462.41M	$465.13M	$397.60M	$364.74M

Key ratios

Key ratios
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Revenue growth, YoY	9.3%	12.1%	9.9%	11.5%	12.7%	5.7%	6.9%	9.7%	4.3%	8.0%
Net income growth, YoY	3.0%	-13.5%	2.7%	10.3%	-	-	-48.4%	355.0%	-74.5%	-
EPS growth, YoY	5.7%	-11.7%	6.1%	8.8%	-	-	-46.3%	359.1%	-74.1%	-
Gross margin	3.6%	3.4%	3.4%	3.5%	3.2%	2.7%	2.9%	2.7%	3.0%	2.9%
Operating margin	0.8%	0.7%	0.9%	1.0%	1.1%	-2.7%	0.6%	0.9%	0.7%	1.0%
Net margin	0.5%	0.5%	0.7%	0.7%	0.7%	-1.8%	0.5%	1.0%	0.2%	1.0%
Free cash flow margin	1.0%	1.0%	1.3%	0.9%	1.0%	1.0%	1.1%	0.6%	0.7%	1.8%
Return on equity	103.1%	191.8%	261.9%	2383.5%	263.5%	-	28.6%	54.4%	17.7%	67.1%
Return on assets	2.0%	2.2%	2.8%	3.0%	2.7%	-7.7%	2.2%	4.4%	1.0%	4.2%
Current ratio	0.90	0.88	0.88	0.91	0.94	0.98	0.95	0.93	0.91	0.90
Debt to equity	5.08	5.58	7.19	80.01	11.44	-	1.39	1.41	1.67	1.97

Income statement

Income statement
Line item	Q3 2026 Jun 30, 2026	Q2 2026 Mar 31, 2026	Q1 2026 Dec 31, 2025	Q4 2025* Sep 30, 2025	Q3 2025 Jun 30, 2025	Q2 2025 Mar 31, 2025	Q1 2025 Dec 31, 2024	Q4 2024* Sep 30, 2024	Q3 2024 Jun 30, 2024	Q2 2024 Mar 31, 2024	Q1 2024 Dec 31, 2023	Q4 2023* Sep 30, 2023
Revenue	$84.75B	$78.36B	$85.93B	$83.73B	$80.66B	$75.45B	$81.49B	$79.05B	$74.24B	$68.41B	$72.25B	$68.92B
Cost of revenue	$81.15B	$74.77B	$82.86B	$80.77B	$77.76B	$72.39B	$78.93B	$76.56B	$71.83B	$65.88B	$69.78B	$66.67B
Gross profit	$3.61B	$3.59B	$3.07B	$2.95B	$2.91B	$3.06B	$2.56B	$2.49B	$2.41B	$2.54B	$2.47B	$2.25B
Selling, general and admin	$2.13B	$1.98B	$1.80B	$1.75B	$1.67B	$1.60B	$1.47B	$1.49B	$1.38B	$1.39B	$1.40B	$1.39B
Operating income	$1.12B	$1.14B	$760.45M	$18.50M	$867.65M	$1.04B	$706.25M	$126.64M	$672.48M	$553.26M	$822.88M	$476.94M
Pre-tax income	$996.39M	$2.09B	$708.64M	-$187.04M	$896.28M	$928.66M	$620.45M	$125.18M	$628.33M	$467.07M	$783.40M	$446.42M
Income tax	$219.73M	$459.04M	$142.51M	$146.03M	$206.53M	$211.24M	$126.73M	$117.71M	$140.74M	$45.86M	$180.39M	$97.44M
Net income	$763.52M	$1.64B	$559.65M	-$339.70M	$687.40M	$717.87M	$488.60M	$3.38M	$483.46M	$420.77M	$601.50M	$350.56M
EPS, basic	$3.95	$8.44	$2.88	-$1.75	$3.55	$3.70	$2.52	$0.04	$2.44	$2.11	$3.01	$1.75
EPS, diluted	$3.94	$8.40	$2.87	-$1.74	$3.52	$3.68	$2.50	$0.04	$2.42	$2.09	$2.98	$1.72
Diluted shares	193.9M	195.4M	195.3M	-	195.2M	195.1M	195.2M	-	200.0M	201.2M	201.8M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Jun 30, 2026	Q2 2026 Mar 31, 2026	Q1 2026 Dec 31, 2025	Q4 2025* Sep 30, 2025	Q3 2025 Jun 30, 2025	Q2 2025 Mar 31, 2025	Q1 2025 Dec 31, 2024	Q4 2024* Sep 30, 2024	Q3 2024 Jun 30, 2024	Q2 2024 Mar 31, 2024	Q1 2024 Dec 31, 2023	Q4 2023* Sep 30, 2023
Cash and equivalents	$2.82B	$2.18B	$1.75B	$4.36B	$2.23B	$1.98B	$3.22B	$3.13B	$3.31B	$2.07B	$2.87B	$2.59B
Receivables	$25.45B	$24.89B	$25.98B	$25.23B	$24.56B	$23.72B	$24.55B	$23.87B	$24.05B	$22.64B	$21.58B	$20.91B
Inventory	$21.03B	$20.01B	$24.08B	$20.49B	$20.14B	$18.97B	$20.51B	$19.00B	$18.30B	$17.63B	$18.65B	$17.45B
Current assets	$55.34B	$53.14B	$54.15B	$52.24B	$48.81B	$46.53B	$49.99B	$47.72B	$47.31B	$44.16B	$44.86B	$42.80B
Goodwill	$16.52B	$16.45B	$13.73B	$13.68B	$14.33B	$14.09B	$9.18B	$9.32B	$9.61B	$9.62B	$9.66B	$9.57B
Total assets	$83.81B	$81.65B	$78.36B	$76.59B	$73.96B	$71.19B	$69.05B	$67.10B	$66.77B	$63.87B	$64.69B	$62.56B
Current liabilities	$59.20B	$56.13B	$59.13B	$57.82B	$53.96B	$53.33B	$54.51B	$54.28B	$52.97B	$49.76B	$50.77B	$48.83B
Short-term debt	$279.15M	$202.66M	$342.28M	$117.78M	$196.79M	$770.32M	$2.21B	$576.33M	$565.11M	$1.07B	$592.78M	$641.34M
Long-term debt	$11.44B	$12.18B	$7.58B	$7.54B	$8.04B	$7.09B	$5.94B	$3.81B	$4.17B	$4.18B	$4.19B	$4.15B
Total debt	$11.72B	$12.39B	$7.92B	$7.66B	$8.24B	$7.86B	$8.15B	$4.39B	$4.73B	$5.25B	$4.78B	$4.79B
Total liabilities	$80.57B	$78.07B	$76.27B	$74.84B	$71.75B	$70.01B	$68.69B	$66.31B	$65.71B	$62.64B	$63.63B	$61.89B
Shareholders' equity	$3.05B	$3.58B	$2.10B	$1.51B	$2.21B	$1.18B	$361.90M	$786.74M	$1.06B	$1.23B	$1.06B	$666.29M

Cash flow

Cash flow
Line item	Q3 2026 Jun 30, 2026	Q2 2026 Mar 31, 2026	Q1 2026 Dec 31, 2025	Q4 2025* Sep 30, 2025	Q3 2025 Jun 30, 2025	Q2 2025 Mar 31, 2025	Q1 2025 Dec 31, 2024	Q4 2024* Sep 30, 2024	Q3 2024 Jun 30, 2024	Q2 2024 Mar 31, 2024	Q1 2024 Dec 31, 2023	Q4 2023* Sep 30, 2023
Operating cash flow	$2.65B	$1.34B	-$2.31B	$3.13B	$109.25M	$3.35B	-$2.72B	$1.00B	$2.48B	-$878.44M	$885.16M	$1.83B
Capital expenditures	$226.04M	$165.62M	$119.38M	$249.81M	$183.22M	$129.06M	$105.89M	$182.32M	$117.88M	$112.75M	$74.22M	$175.50M
Free cash flow	$2.43B	$1.17B	-$2.42B	$2.88B	-$73.97M	$3.22B	-$2.82B	$818.05M	$2.36B	-$991.20M	$810.94M	$1.65B
Investing cash flow	-$240.15M	-$4.87B	-$299.31M	-$321.94M	-$234.69M	-$4.08B	-$343.04M	-$241.88M	-$143.92M	-$166.49M	-$65.80M	-$183.44M
Financing cash flow	-$1.77B	$3.98B	$43.20M	-$683.78M	$215.48M	-$491.74M	$3.21B	-$957.26M	-$1.15B	$323.17M	-$551.67M	-$407.01M
Dividends paid	$116.59M	$117.46M	$126.52M	$107.51M	$107.49M	$111.19M	$110.89M	$100.94M	$102.53M	$107.00M	$105.69M	$98.34M
Share repurchases	-	-	-	$71.0K	$0	$50.00M	$385.40M	$504.98M	$550.01M	$50.84M	$385.53M	$273.51M
Stock-based compensation	$28.73M	$28.00M	$66.05M	$25.94M	$23.18M	$28.45M	$70.38M	$34.59M	$22.18M	$28.16M	$63.08M	$24.93M
Depreciation and amortization	$269.50M	$249.29M	$260.40M	$258.77M	$254.00M	$259.82M	$278.49M	-	-	-	-	-

Key ratios

Key ratios
Line item	Q3 2026 Jun 30, 2026	Q2 2026 Mar 31, 2026	Q1 2026 Dec 31, 2025	Q4 2025* Sep 30, 2025	Q3 2025 Jun 30, 2025	Q2 2025 Mar 31, 2025	Q1 2025 Dec 31, 2024	Q4 2024* Sep 30, 2024	Q3 2024 Jun 30, 2024	Q2 2024 Mar 31, 2024	Q1 2024 Dec 31, 2023	Q4 2023* Sep 30, 2023
Revenue growth, YoY	5.1%	3.8%	5.5%	5.9%	8.7%	10.3%	12.8%	14.7%	10.9%	7.8%	15.0%	12.7%
Net income growth, YoY	11.1%	128.6%	14.5%	-	42.2%	70.6%	-18.8%	-99.0%	0.8%	-3.4%	25.4%	18.9%
EPS growth, YoY	11.9%	128.3%	14.8%	-	45.5%	76.1%	-16.1%	-	3.0%	-1.9%	27.9%	22.9%
Gross margin	4.3%	4.6%	3.6%	3.5%	3.6%	4.1%	3.1%	3.2%	3.2%	3.7%	3.4%	3.3%
Operating margin	1.3%	1.5%	0.9%	0.0%	1.1%	1.4%	0.9%	0.2%	0.9%	0.8%	1.1%	0.7%
Net margin	0.9%	2.1%	0.7%	-0.4%	0.9%	1.0%	0.6%	0.0%	0.7%	0.6%	0.8%	0.5%
Free cash flow margin	2.9%	1.5%	-2.8%	3.4%	-0.1%	4.3%	-3.5%	1.0%	3.2%	-1.4%	1.1%	2.4%
Current ratio	0.93	0.95	0.92	0.90	0.90	0.87	0.92	0.88	0.89	0.89	0.88	0.88
Debt to equity	3.84	3.45	3.78	5.08	3.73	6.66	22.52	5.58	4.46	4.28	4.50	7.19

Source: XBRL data Cencora Inc. files with the SEC, latest filing dated Aug 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

COR peers

Company	Revenue	Growth	Net income	Net margin	Market cap
COR	$332.77B	+5.1%	$2.62B	0.8%	$63.65B
MCKMcKesson Corporation	$418.79B	+8.2%	$4.70B	1.1%	$122.48B
CAHCardinal Health Inc.	$254.25B	+14.2%	$1.71B	0.7%	$62.92B
HLFHerbalife Ltd.	$5.28B	+6.4%	$179.80M	3.4%	$1.60B
NUSNu Skin Enterprises Inc.	$1.32B	-15.3%	-$234.21M	-17.7%	$199.4M
ZSTKZeroStack Corp.	$40.03M	+27.3%	-$177.84M	-444.2%	$55.0M
ESYNEnerSyn Global Inc.	$389.7K	-68.5%	-$2.65M	-680.2%	$48.5M
COSMCosmos Health Inc.	$73.73M	+33.8%	-$24.39M	-33.1%	$30.2M
MEDSDataMeds AI Inc.	$8.02M	-78.2%	-$88.28M	-1100.3%	$5.7M

COR FAQ

9 questions

What is COR revenue?
Cencora Inc. (COR) reported $332.77B of revenue for the twelve months ended Jun 30, 2026. That is up 5.1% from the year before. Revenue for fiscal 2025 was $321.33B.
Is COR profitable?
Yes. Cencora Inc. earned $2.62B in net income for the twelve months ended Jun 30, 2026, a net margin of 0.8%.
How much cash and debt does COR have?
Cencora Inc. reported $2.82B in cash and cash equivalents and $11.72B of debt on its most recent balance sheet in SEC filings.
How fast is COR revenue growing?
Cencora Inc.'s revenue changed +9.3% in fiscal 2025, to $321.33B. Its compound annual growth rate was +11.1% over 5 years and +9.0% over 10 years.
What is COR gross margin?
Cencora Inc.'s gross profit was $13.22B on $332.77B of revenue for the twelve months ended Jun 30, 2026, a gross margin of 4.0%.
What is COR free cash flow?
Cencora Inc. generated $4.06B of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of $4.82B less capital expenditures.
What is COR earnings per share?
Diluted earnings per share were $13.47 for the twelve months ended Jun 30, 2026, from SEC filings, restated for any stock split those filings show.
When did COR last report financial results?
The latest statements here come from Cencora Inc.'s 10-Q filed on Aug 5, 2026, covering the period ended Jun 30, 2026.
Where does this COR financial data come from?
Quantisnow builds these statements from the structured XBRL data Cencora Inc. files with the SEC. It is provided for information only and is not investment advice.